FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206280370> ?p ?o ?g. }

• W3206280370 abstract "Background: Trastuzumab is an efficient monoclonal antibody used in the treatment of Her2-positive breast cancer. Despite its prominent effect on Her2-positive patients' disease-free Survival. Trastuzumab-induced cardiotoxicity is still one of the main challenges. Angiotensin-converting enzyme inhibitors (ACE inhibitors) are one of the most potent agents used in heart failure, which also showed confirmed cardioprotective effects against anthracycline and doxorubicin. We aimed to assess the cardioprotective effects of Carvedilol in a randomized clinical trial study. Materials and Methods: sixty non-metastatic Her-2 positive patients (30 cases; 30 controls) were entered into the study via a simple randomization method.Carvedilol was administered for the patients with the starting dose of 3.125 mg twice a day and started 7 days before trastuzumab administration. The dose has been increased in a three-week period to reach 12.5 mg twice a day and continued until the end of therapy. All the patients underwent an echocardiography after receiving Adriamycin and Cyclophosphamide in order to measure basal Ejection Fraction (EF) and Pulmonary Artery Pressure (PAP). Each patient underwent a follow-up echocardiography in 3,6,9 and 12 months after initiation of the treatment. Finally, all the patients went through the last episode of echocardiography 1 month after the end of treatment. All the Measured PAP and EF has been recorded and analyzed Results: EF and PAP changes for both groups had no significant changes during the course of treatment with Trastuzmab (p-value = 0.628 and p-value = 0.723, respectively). Seven patients in the intervention group and 2 patients in the control group presented with EF decrease. Also, 8 patients in the intervention and 9 patients in the control groups showed PAP increase. Conclusion: According to our results, in patients with HER2-positive breast cancer treated with trastuzumab, Carvedilol showed no significant protective effect on trastuzumab-induced cardiotoxicity." @default.
• W3206280370 created "2021-10-25" @default.
• W3206280370 creator A5000111349 @default.
• W3206280370 creator A5009355542 @default.
• W3206280370 creator A5024138276 @default.
• W3206280370 creator A5034684091 @default.
• W3206280370 creator A5039968983 @default.
• W3206280370 creator A5060650722 @default.
• W3206280370 date "2021-10-17" @default.
• W3206280370 modified "2023-09-30" @default.
• W3206280370 title "Evaluation of the Preventive Effects of Carvedilol on Trastuzumab-Induced Cardiotoxicity in Early-Stage and Locally Advanced HER2-Positive Breast Cancer Patients" @default.
• W3206280370 cites W1980538880 @default.
• W3206280370 cites W1981345102 @default.
• W3206280370 cites W2007256480 @default.
• W3206280370 cites W2029542561 @default.
• W3206280370 cites W2045570557 @default.
• W3206280370 cites W2048686497 @default.
• W3206280370 cites W2056918035 @default.
• W3206280370 cites W2066023275 @default.
• W3206280370 cites W2066930871 @default.
• W3206280370 cites W2076188742 @default.
• W3206280370 cites W2099545363 @default.
• W3206280370 cites W2103414003 @default.
• W3206280370 cites W2115847479 @default.
• W3206280370 cites W2122472092 @default.
• W3206280370 cites W2133105825 @default.
• W3206280370 cites W2133304247 @default.
• W3206280370 cites W2136166698 @default.
• W3206280370 cites W2141393790 @default.
• W3206280370 cites W2150181183 @default.
• W3206280370 cites W2151262170 @default.
• W3206280370 cites W2159845849 @default.
• W3206280370 cites W2162488896 @default.
• W3206280370 cites W2170401504 @default.
• W3206280370 cites W2339938475 @default.
• W3206280370 cites W2538711370 @default.
• W3206280370 cites W2546933023 @default.
• W3206280370 cites W2558002415 @default.
• W3206280370 cites W2582393800 @default.
• W3206280370 cites W2587882014 @default.
• W3206280370 cites W2789300675 @default.
• W3206280370 cites W2806209829 @default.
• W3206280370 cites W2889646458 @default.
• W3206280370 cites W2948656647 @default.
• W3206280370 doi "https://doi.org/10.18502/ijhoscr.v15i4.7475" @default.
• W3206280370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35291664" @default.
• W3206280370 hasPublicationYear "2021" @default.
• W3206280370 type Work @default.
• W3206280370 sameAs 3206280370 @default.
• W3206280370 citedByCount "5" @default.
• W3206280370 countsByYear W32062803702023 @default.
• W3206280370 crossrefType "journal-article" @default.
• W3206280370 hasAuthorship W3206280370A5000111349 @default.
• W3206280370 hasAuthorship W3206280370A5009355542 @default.
• W3206280370 hasAuthorship W3206280370A5024138276 @default.
• W3206280370 hasAuthorship W3206280370A5034684091 @default.
• W3206280370 hasAuthorship W3206280370A5039968983 @default.
• W3206280370 hasAuthorship W3206280370A5060650722 @default.
• W3206280370 hasBestOaLocation W32062803701 @default.
• W3206280370 hasConcept C121608353 @default.
• W3206280370 hasConcept C126322002 @default.
• W3206280370 hasConcept C143998085 @default.
• W3206280370 hasConcept C164705383 @default.
• W3206280370 hasConcept C2775930923 @default.
• W3206280370 hasConcept C2776694085 @default.
• W3206280370 hasConcept C2776755627 @default.
• W3206280370 hasConcept C2776802502 @default.
• W3206280370 hasConcept C2778198053 @default.
• W3206280370 hasConcept C2778213512 @default.
• W3206280370 hasConcept C2778233292 @default.
• W3206280370 hasConcept C2779786085 @default.
• W3206280370 hasConcept C2780591200 @default.
• W3206280370 hasConcept C2781303535 @default.
• W3206280370 hasConcept C530470458 @default.
• W3206280370 hasConcept C71924100 @default.
• W3206280370 hasConcept C78085059 @default.
• W3206280370 hasConceptScore W3206280370C121608353 @default.
• W3206280370 hasConceptScore W3206280370C126322002 @default.
• W3206280370 hasConceptScore W3206280370C143998085 @default.
• W3206280370 hasConceptScore W3206280370C164705383 @default.
• W3206280370 hasConceptScore W3206280370C2775930923 @default.
• W3206280370 hasConceptScore W3206280370C2776694085 @default.
• W3206280370 hasConceptScore W3206280370C2776755627 @default.
• W3206280370 hasConceptScore W3206280370C2776802502 @default.
• W3206280370 hasConceptScore W3206280370C2778198053 @default.
• W3206280370 hasConceptScore W3206280370C2778213512 @default.
• W3206280370 hasConceptScore W3206280370C2778233292 @default.
• W3206280370 hasConceptScore W3206280370C2779786085 @default.
• W3206280370 hasConceptScore W3206280370C2780591200 @default.
• W3206280370 hasConceptScore W3206280370C2781303535 @default.
• W3206280370 hasConceptScore W3206280370C530470458 @default.
• W3206280370 hasConceptScore W3206280370C71924100 @default.
• W3206280370 hasConceptScore W3206280370C78085059 @default.
• W3206280370 hasLocation W32062803701 @default.
• W3206280370 hasLocation W32062803702 @default.
• W3206280370 hasLocation W32062803703 @default.
• W3206280370 hasLocation W32062803704 @default.
• W3206280370 hasOpenAccess W3206280370 @default.
• W3206280370 hasPrimaryLocation W32062803701 @default.
• W3206280370 hasRelatedWork W1993230245 @default.

• next